Israel Englander Biote Corp. Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.44 - $7.47 $156,383 - $214,740	28,747 Added 31.63%	119,631 $893,000
Q1 2024 May 15, 2024	BUY	$3.79 - $6.91 $259,357 - $472,865	68,432 Added 304.79%	90,884 $527,000
Q4 2023 Feb 14, 2024	SELL	$4.43 - $5.81 $51,751 - $67,872	-11,682 Reduced 34.22%	22,452 $110,000
Q2 2023 Aug 14, 2023	BUY	$5.27 - $6.9 $179,886 - $235,524	34,134 New	34,134 $230,000
Q4 2022 Feb 14, 2023	SELL	$3.73 - $4.6 $186,153 - $229,572	-49,907 Reduced 83.31%	10,000 $37,000
Q3 2022 Nov 14, 2022	SELL	$3.48 - $4.98 $202,372 - $289,601	-58,153 Reduced 49.26%	59,907 $256,000

17.7M

Ticker BTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 7,574,270
Market Cap $50.1M
Description
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.